UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

JAMA neurology, 2020-02, Vol.77 (2), p.184

2020

Volltextzugriff (PDF)

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Annals of neurology, 2020-05, Vol.87 (5), p.688-699

2020

Volltextzugriff (PDF)

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9700), p.1503-1511

2009

Volltextzugriff (PDF)

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Journal of neurology, neurosurgery and psychiatry, 2024, Vol.95 (2), p.134-141

2024

Volltextzugriff (PDF)

Cancer risk among patients with multiple sclerosis and their parents

Neurology, 2009-03, Vol.72 (13), p.1170-1177

2009

Volltextzugriff (PDF)

Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity

Journal of internal medicine, 2021-08, Vol.290 (2), p.473-476

2021

Volltextzugriff (PDF)

Changes to anti-JCV antibody levels in a Swedish national MS cohort

Journal of neurology, neurosurgery and psychiatry, 2013-11, Vol.84 (11), p.1199-1205

2013

Volltextzugriff (PDF)

In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent

Journal of neurology, neurosurgery and psychiatry, 2008-01, Vol.79 (1), p.57-62

2008

Volltextzugriff (PDF)

Long-term disability progression of pediatric-onset multiple sclerosis

Neurology, 2019-06, Vol.92 (24), p.e2764

2019

Volltextzugriff (PDF)

A longitudinal study of variations in and predictors of fatigue in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2008-04, Vol.79 (4), p.454-457

2008

Volltextzugriff (PDF)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study

Neurology, 2019-12, Vol.93 (24), p.e2216

2019

Volltextzugriff (PDF)

Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden

JAMA neurology, 2019-06, Vol.76 (6), p.665

2019

Volltextzugriff (PDF)

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies

JAMA neurology, 2021-10, Vol.78 (10), p.1197

2021

Volltextzugriff (PDF)

HLA-DRB1 and month of birth in multiple sclerosis

Neurology, 2009-12, Vol.73 (24), p.2107-2111

2009

Volltextzugriff (PDF)

Blockade of chemokine signaling in patients with multiple sclerosis

Neurology, 2006-11, Vol.67 (10), p.1880-1883

2006

Volltextzugriff (PDF)

A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort

Neurology, 2006-06, Vol.66 (12), p.1888-1893

2006

Volltextzugriff (PDF)

Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis

JAMA neurology, 2019-09, Vol.76 (9), p.1028

2019

Volltextzugriff (PDF)

A common haplotype of the C‐C chemokine receptor 2 gene and HLA‐DRB10301 are independent genetic risk factors for Löfgren’s syndrome

Journal of internal medicine, 2008-11, Vol.264 (5), p.433-441

2008

Volltextzugriff (PDF)

Familial effects on the clinical course of multiple sclerosis

Neurology, 2007-01, Vol.68 (5), p.376-383

2007

Volltextzugriff (PDF)

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

Neurology, 1998-03, Vol.50 (3), p.708-714

1998

Volltextzugriff (PDF)

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study

Journal of neurology, neurosurgery and psychiatry, 2023-04, Vol.94 (4), p.284-289

2023

Volltextzugriff (PDF)

Investigation of the Effect of Human Leukocyte Antigen on the Development of Neutralizing Antibodies in Interferon-beta Treated Patients with Multiple Sclerosis (The First Three Authors Contributed Equally to This Work) (P05.121)

Neurology, 2012, Vol.78 (Meeting Abstracts 1), p.P05-P05.121

2012

Volltextzugriff (PDF)

Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study

Neurology, 2020-12, Vol.95 (22), p.1026-1026

2020

Volltextzugriff (PDF)

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Proceedings of the National Academy of Sciences - PNAS, 2019-08, Vol.116 (34), p.16955-16960

2019

Volltextzugriff (PDF)

Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis

JAMA neurology, 2021-04, Vol.78 (4), p.478

2021

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Cancer risk among patients with multiple sclerosis and their parents

Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity

Changes to anti-JCV antibody levels in a Swedish national MS cohort

In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent

Long-term disability progression of pediatric-onset multiple sclerosis

A longitudinal study of variations in and predictors of fatigue in multiple sclerosis

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study

Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies

HLA-DRB1 and month of birth in multiple sclerosis

Blockade of chemokine signaling in patients with multiple sclerosis

A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort

Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis

A common haplotype of the C‐C chemokine receptor 2 gene and HLA‐DRB10301 are independent genetic risk factors for Löfgren’s syndrome

Familial effects on the clinical course of multiple sclerosis

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study

Investigation of the Effect of Human Leukocyte Antigen on the Development of Neutralizing Antibodies in Interferon-beta Treated Patients with Multiple Sclerosis (The First Three Authors Contributed Equally to This Work) (P05.121)

Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis

Aktive Filter

Suchergebnisse filtern